Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients
- 355 Downloads
Improvements in survival after septic shock will most likely rely on our capacity to manage individualized therapies based on the measurement of rapidly accessible biomarkers. As the early phase of septic shock is dominated by severe alterations of the cardiovascular system, the predictive value for mortality of pro-vasopressin (pro-AVP) and pro-adrenomedullin (pro-ADM), two vasoactive pro-hormones, was assessed.
In 99 consecutive patients, pro-hormone concentrations were measured (immunoluminometric assay) three times within the first week after the onset of septic shock.
Pro-AVP and pro-ADM concentrations were significantly increased in non-survivors in comparison with survivors and were significantly associated with mortality after both univariate and multivariate analysis. Importantly, when assessed as a pair, pro-ADM and pro-AVP were even more informative.
Both Pro-ADM and pro-AVP appear to be good biomarkers for the prediction of 28-day mortality after septic shock. However, their association in a single variable tends to improve their predictive capacity.
KeywordsSeptic shock Mortality Prognosis Adrenomedullin Vasopressin
This work was supported by the Hospices Civils de Lyon and was conducted thanks to the support of Brahms—we especially thank Dr. N.G. Morgenthaler and Dr. A. Bergmann. All measurements were performed in the Research Department of Brahms AG in a totally blinded fashion without knowledge of clinical parameters. This work was also conducted thanks to the logistical support (H. Thizy, F. Gueyffier) from the Centre d’Investigation Clinique (CIC 201) de Lyon (Clinical Research Centre) of INSERM and Hospices Civils de Lyon.
- 7.Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent JL, Zanotti-Cavazzoni S (2004) Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32:1928–1948CrossRefPubMedGoogle Scholar
- 20.Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T, CAPNETZ Study Group (2007) CAPNETZ Study Group: pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 33:2069–2078CrossRefPubMedGoogle Scholar
- 23.McCabe WR, Jackson GC (1962) Gram-negative bacteremia. Arch Intern Med 110:847–864Google Scholar
- 25.Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 26:1793–1800PubMedGoogle Scholar
- 29.Khan SQ, Dhillon O, Struck J, Quinn P, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (2007) C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester acute myocardial infarction peptide (LAMP) study. Am Heart J 154:736–742CrossRefPubMedGoogle Scholar
- 30.Khan SQ, O’Brien RJ, Struck J, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (2007) Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester acute myocardial infarction peptide) study. J Am Coll Cardiol 49:1525–1532CrossRefPubMedGoogle Scholar
- 31.Khan SQ, Dhillon OS, O’Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (2007) C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester acute myocardial infarction peptide (LAMP) study. Circulation 115:2103–2110CrossRefPubMedGoogle Scholar